<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220201053910N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-07-04</date_registration>
      <primary_sponsor>Karaj University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the result of intramedullary nailing by static and dynamic methods</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the results of intramedullary nailing by static and dynamic methods in the erosion of femur and tibia shaft fractures.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-04-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>102</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/61888</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, after obtaining the informed consent of eligible individuals, individuals will be randomly divided into two groups: static and dynamic IMN. For this purpose, quadruple blocks (A, A, B, B) will be created and two groups of people will be formed in each block. These blocks are created randomly so that in each group, the number of people in the study stage is almost equal. Therefore, at each stage of the study, a block (allocation of four symbols inside the block is random and there are many blocks) is randomly selected and then people will assign to the relevant group in the order in which the block appears.  (A group will be static IMN, B group will be dynamic IMN).</study_design>
      <phase>N/A</phase>
      <hc_freetext>Fractures of the femoral shaft and tibia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this group, the static intramedullary nailing method will be used to fix the fracture in such a way that 3 to 4 screws are used at both ends to prevent vertical and rotational instability and bending. Intervention 2: Control group: In this group, the dynamic intramedullary nailing method will be used. In this way, a distal or proximal screw will be used that allows vertical pressure to control rotational instability and bending.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
1. Participants' data file will be shared after de-identifying individuals
2- The study protocol will be shared after the study
3- The statistical analysis map will be shared after the study
4- The informed consent form will be shared after the study
5- The statistical analysis map will be shared after the study
6. The clinical study report will be shared after the study
7. The codes used in the analysis will be shared after the study
8. The data classification system will be shared after the study

When:
The data access period will start 6 months after the publication of the study results

To whom:
All people working in the field of medical sciences will be allowed to access the data

Conditions:
Medical researchers can use the results of this study to conduct medical research, provided that they follow the principles of such research, such as non-copying.

Where to obtain:
Applicants can refer to the Clinical Research Development Unit of Madani Karaj Hospital at the address of Karaj, Mahan Blvd., Madani Hospital, Clinical Research Development Unit, to receive data.
They can also email sedighiali112@gmail.com

How to obtain:
Applicants' request for data use will be reviewed by the Clinical Research Development Unit of the Civil Hospital and if this unit agrees, the data will be provided to the applicants.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ali Sedighi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mahan blvd-Shahid madani hospital-Clinical Research Development Unit</address>
        <city>Karaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۳۱۴۳۷۴۴۶۹۳</zip>
        <telephone>+98 26 3420 9028</telephone>
        <email>sedighiali112@gmail.com</email>
        <affiliation>Karaj University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ali Sedigi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mahan blvd-Shahid madani hospital-Clinical Research Development Unit</address>
        <city>karaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۳۱۴۳۷۴۴۶۹۳</zip>
        <telephone>+98 26 3420 9028</telephone>
        <email>sedighiali112@gmail.com</email>
        <affiliation>Karaj University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>18 to 80 years old
Informed consent
Having a fracture of the transverse or short inclination type
The time to go to the hospital is less than two weeks after the fracture</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Open fractures
Fractures with chopped parts
Fractures associated with neurovascular injuries
Fractures previously treated with IMN or periprosthetic fractures
Diabetes
Osteoporosis</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this group, the static intramedullary nailing method will be used to fix the fracture in such a way that 3 to 4 screws are used at both ends to prevent vertical and rotational instability and bending.</i_keyword>
      <i_keyword>Control group: In this group, the dynamic intramedullary nailing method will be used. In this way, a distal or proximal screw will be used that allows vertical pressure to control rotational instability and bending.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The final result of welding based on clinical and radiological evaluation (Harper criteria). Timepoint: Examinations will be done immediately after the surgery and then 8 weeks later and after that at intervals of 4 weeks to 6 months and the last visit and imaging will be done 9 to 21 months after the surgery. Method of measurement: Patients in both groups will be regularly examined and visited and photographed in two views and profile of the fracture site.</prim_outcome>
      <prim_outcome>Duration of complete welding. Timepoint: Examinations will be done immediately after the surgery and then 8 weeks later and after that at intervals of 4 weeks to 6 months and the last visit and imaging will be done 9 to 21 months after the surgery. Method of measurement: Patients in both groups will be regularly examined and visited and photographed in two views and profile of the fracture site.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Karaj University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-09-20</approval_date>
        <contact_name>Ethics Committee of Alborz University of Medical Sciences</contact_name>
        <contact_address>mahan blvd-shahid madani hospital-Clinical Research Development Unit karaj Alborz Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
